Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa
about
Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysisMarked sex differences in all-cause mortality on antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysisHigh-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South AfricaAntiretroviral therapy: Shifting sandsImmunological failure of first-line and switch to second-line antiretroviral therapy among HIV-infected persons in Tanzania: analysis of routinely collected national data.Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic reviewPredicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.Magnitude and predictors of antiretroviral treatment failure among HIV-infected children in Fiche and Kuyu hospitals, Oromia region, Ethiopia: a retrospective cohort study.Changes in second-line regimen durability and continuity of care in relation to national ART guideline changes in South AfricaTreatment outcomes in a decentralized antiretroviral therapy program: a comparison of two levels of care in north central Nigeria.A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.Association of HIV/AIDS Clinician Warm Line Utilization with Diagnosis and Management of Antiretroviral Treatment Failure in Mozambique: A Retrospective Analysis of Program DataEffectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil.Gender-specific risk factors for virologic failure in KwaZulu-Natal: automobile ownership and financial insecurity.Household-based HIV counseling and testing as a platform for referral to HIV care and medical male circumcision in Uganda: a pilot evaluationSAMBA HIV semiquantitative test, a new point-of-care viral-load-monitoring assay for resource-limited settingsDelayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa.Persistent difficulties in switching to second-line ART in sub-saharan Africa--a systematic review and meta-analysis.Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland.Implementing antiretroviral resistance testing in a primary health care HIV treatment programme in rural KwaZulu-Natal, South Africa: early experiences, achievements and challenges.Dried blood spots for viral load monitoring in Malawi: feasible and effectiveMonitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysisThe HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.Projected economic evaluation of the national implementation of a hypothetical HIV vaccination program among adolescents in South Africa, 2012.Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithmMarginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa.Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first-line ART in Myanmar, 2005-2015Impact of a clinical program using weekly Short Message Service (SMS) on antiretroviral therapy adherence support in South Africa: a retrospective cohort study.Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South AfricaTreatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South AfricaGenetic Analysis of HIV-1 Integrase Sequences from Treatment Naive Individuals in Northeastern South Africa.Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa.Sustainable HIV treatment in Africa through viral-load-informed differentiated care.Developing a predictive risk model for first-line antiretroviral therapy failure in South AfricaCan Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa.Early warning indicators for first-line virologic failure independent of adherence measures in a South African urban clinic.Novel pH sensing semiconductor for point-of-care detection of HIV-1 viremia.The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso.
P2860
Q27021762-A4B8B2B3-8D3A-46B3-8A54-6296F07F1B62Q28068815-648D9479-A441-4542-A1D8-90728975B64EQ28535483-6C3734BA-B9BF-49BA-A552-1A3F0297744AQ30384683-0395485D-E84A-4F89-BF83-F09FCF24BA3AQ30911364-308F2F38-DDC3-40B6-981E-DCEFF033FA0AQ33566578-2E77795A-798A-4848-8374-02C4B8F38E1FQ33733440-FCD6E613-BE58-41DF-B3E1-DB7A0E335C70Q33771383-0BEB06B6-28F6-4662-BF12-26C750AB4284Q33777513-CE0E59F6-0372-462F-AB7E-A541BCA84AB0Q33852863-4E45A315-D836-4EF9-9E16-E2CB911427E4Q33868639-A3BD3A19-8A3A-4FF6-9464-384C70F4D250Q33904819-CCC5C37D-C514-4524-B149-BF1FE2D5350BQ34153838-D8D49DA8-4A77-42A0-BB01-3F33D1F51B31Q34345205-453FE81B-FC63-47CC-9851-C0D106A475ADQ34525382-BCED3B15-4DA7-4F58-A847-A874CED6384BQ35035797-F72EF1A1-20C8-4270-9C3C-988F866A833CQ35049762-CC0B9D1F-FC09-4952-901F-9F9BEDE0E205Q35077695-60C47B47-A8B9-41BA-A52C-E4C49E75431FQ35103348-574B739D-9537-4EE4-AF59-108CC0DDF950Q35114102-6D0B4507-8EE7-44EE-8C69-73282FA645C3Q35515391-CD675AC1-EF3D-48B2-AACB-7CCE3D8B339EQ35847158-52874D24-A9EE-4551-B0E3-ECA1044A7D53Q35850530-3A4A5293-CA4C-4FC1-A728-8ED1A643211FQ35990326-0B53A002-A8CD-4FDA-8DA6-26018290940FQ36050916-B9F7C0D8-7038-4C9B-897D-C285C771E81EQ36109276-1487A38C-7F03-43C7-A896-6B52F2E577B0Q36224801-CB295857-266E-4F2C-926A-84746B4AE687Q36226907-9278625A-94AB-48DC-AADC-FEE4DF2EAD0EQ36275812-327B6BA5-1B65-409A-8BFD-4DB22D66DEC6Q36285679-AA67A561-164D-4A17-AAC7-2A5FBCFCE5B5Q36380146-EDF8E68B-57A2-4F59-958C-BCEFFD998A88Q36463979-1C4792B7-105B-43BE-A9B6-AB939A66248AQ36790317-9F324D13-5BBE-444D-97D9-FFBF5257ECF9Q37003072-9EA57932-0BBB-4A2A-A825-3D8C71C18399Q37064741-0F3B0811-6476-49D4-98A4-4A01A77F34F3Q37290134-23EAE961-F4EB-48DD-A1FF-D2A9BE17C65DQ37348464-D46E52BE-883B-40B0-94A7-1ABEBC359E91Q37403995-E113E575-7795-4D68-8335-CAB2EF03BAAAQ37405560-0B78BB11-FE08-4E8B-8BD7-47BE4E4C9277Q37491656-FBF6F5CA-9D6F-4E02-99CE-E36E54D9F37D
P2860
Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Rates and predictors of failur ...... econd-line ART in South Africa
@ast
Rates and predictors of failur ...... econd-line ART in South Africa
@en
type
label
Rates and predictors of failur ...... econd-line ART in South Africa
@ast
Rates and predictors of failur ...... econd-line ART in South Africa
@en
prefLabel
Rates and predictors of failur ...... econd-line ART in South Africa
@ast
Rates and predictors of failur ...... econd-line ART in South Africa
@en
P2093
P2860
P50
P1476
Rates and predictors of failur ...... econd-line ART in South Africa
@en
P2093
Gilles Van Cutsem
Hans Prozesky
IeDEA-SA collaboration
Jonathan A C Sterne
Miguel A Hernán
P2860
P304
P356
10.1097/QAI.0B013E3182557785
P407
P577
2012-08-01T00:00:00Z